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Original Article
Effects of Reconstituted Collagen Matrix on Fates
of Mouse Embryonic Stem Cells Before and After
Induction for Chondrogenic Differentiation
Chiu W. Yeung, Ph.D.,1 Kathryn Cheah, Ph.D.,2 Danny Chan, Ph.D.,2 and Barbara P. Chan, Ph.D.1
Embryonic stem (ES) cells are pluripotent cells with great potential in regenerativemedicine. However, controlling
their differentiation toward homogeneous lineages is challenging. In this study, we aim to investigate the effects of
reconstituted 3D collagen matrix on the fates of mouse ES (mES) cells before and after induction for chondrogenic
differentiation. Specifically, mES cells were encapsulated and cultured in 3D collagen microspheres and exposed
to induction signals at different time points. Growth characteristics and differentiation status of mES cells were
then evaluated. Collagen microspheres provided a suitable microenvironment supporting mES cell growth and
maintaining their undifferentiated status for certain period of time. At later time points, the proportion of un-
differentiated mES cells gradually decreased, accompanied by increasing proportions of mesenchymal progenitor
cells. This suggests the inductive role of collagenmatrix in differentiatingmES cells towardmesenchymal lineages.
Moreover, a lower initial collagen monomer concentration facilitated the differentiation of mES cells into chon-
drogenic lineages, while induction at a later time point associated with a more advanced stage of chondrogenic
differentiation. This indicates that both the initial collagen concentration and the time to induce differentia-
tion significantly affected the fates of mES cells. This study contributes to future development of ES cell–based
therapies.
Introduction
Embryonic stem (ES) cells are pluripotent cells derivedfrom the inner cell mass of blastocysts and are capable of
self-renewal.1–3 ES cells have great potential in tissue engi-
neering and regenerativemedicine since they can differentiate
into multiple cell types.1,4 Nevertheless, one major hurdle in
using ES cells as the cell source for tissue engineering and
regenerative medicine is their tendency to spontaneously
differentiate toward multiple lineages. As a result, it is im-
portant to define the culture conditions and other microen-
vironment for maintenance of the undifferentiated status of
ES cells before devising specific differentiation protocols.
Leukemia inhibitory factor (LIF), together with the feeder
layer support from mitotically inactivated mouse embryonic
fibroblast, is commonly used to maintain the ES cells in an
undifferentiated status,5 which is usually marked by the ex-
pression of Oct3=4, SSEA-1, and Nanog.6–9
To use ES cells for tissue engineering and regenerative
medicine, it is necessary to differentiate ES cells toward a
specific lineage. In reality, ES cells spontaneously differentiate
into cells of all three germ layers,10 usually via the formation
of embryoid body (EB), which is an aggregate of ES cells
similar to the early postimplantation embryo with charac-
teristic morphogenic processes such as cavitation.1,4,11–14
Embryoid bodies are usually generated by suspension cul-
ture,10,15 hanging drops,10,11,16 or forced aggregation17,18 in
the absence of LIF. It is very difficult to obtain sufficient cells
of a single lineage,19 as EBs usually contain heterogeneous
and asynchronous cell populations.20 As a result, one has to
use specialized techniques to isolate the small proportion of
cells of interests from the EBs for further expansion and sub-
sequent differentiation. These techniques include microdis-
section from plated EBs for cells such as chondrocytes16,21–23
and beating cardiomyocytes,24 and flow cytometry–based
sorting from dissociated EB cells for mesenchymal progenitor
cells (MPCs).25 Alternative methods include direct applica-
tion of chondrogenic differentiation medium to EBs,26,27
transfection of ES cells with cell-specific differentiation-
inductive genes such as Osterix for osteoblasts,28 and coculture
of ES cells with limb bud progenitor cells for chondrocytes.29
Nevertheless, one of the biggest challenges in this field is to
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differentiate ES cells into single lineages homogenously.
Otherwise, clinical application would not be feasible.
In cartilage tissue engineering, inductive signals for chon-
drogenic differentiation of ES cells are those from embryonic
cartilage development.30–32 These cell–cell interaction signals
are soluble biological factors such as transforming growth
factor beta,21,30,33,34 bone morphogenic proteins,33,35,36 and
fibroblast growth factor.31 These signals can also be cell–
matrix interaction factors including cell adhesion molecules
such as N-cadherin37,38 and neural cell adhesion molecules,39
and extracellular matrix molecules such as fibronectin, pro-
teoglycans, and collagen.30 However, supplementing soluble
biological signals to the culture medium of stem cells is the
most commonly used approach to induce chondrogenic dif-
ferentiation and cartilage formation, while the roles of other
types of inductive signals are rarely explored.
Owing to the advancement of biomaterial research in re-
cent years, culturing ES cells in 3D biocompatible materials
becomes possible. The major advantages of 3D cultures of ES
cells in biomaterials are (i) a greater expansion capacity,40–42
although spontaneous differentiation is still substantial, and
(ii) the possibility to engineer the specific 3D microenviron-
ment or niche such as the types of matrix11,43,44 and the
physical properties of matrix18,45,46 facilitating ES cell differ-
entiation toward particular lineages.11,26,43 A wide range of
biomaterials have been used for 3D culture systems of ES cells,
for examples, poly-L-lactic acid,18 polyethylene terephthal-
ate,43,47 collagen,45 alginate,46 fibrin,44 Matrigel,43 chitosan,42
and polyethylene glycol.26,44 Collagen is the most abundant
extracellular matrix composition in human tissues. It is a nat-
urally occurring biomaterial with excellent biocompatibility,
negligible immunogenicity, specific interaction with growth
factors and cell adhesionmolecules, and biodegradability.48–50
Recently, we have developed a collagen microencapsulation
method to entrap living cells in collagenmicrospheresmade of
reconstituted nanofibrous meshwork.25 It has been demon-
strated that this biomimetic collagen meshwork provides a
biomimetic microenvironment to support proliferation of
mesenchymal stem cells (MSCs) without compromising their
regeneration potential51 and to facilitate their chondrogenic
differentiation.52
Our ultimate goal is to develop stem cell–based therapies
for cartilage tissue engineering. In this study, we aim to in-
vestigate the effects of reconstituted collagen matrix mesh-
work on the fates of mouse ES (mES) cells before and after
induction for chondrogenic differentiation. Specifically, we
encapsulated and cultured the mES cells in collagen micro-
spheres with different initial collagen monomer concen-
trations and evaluated their growth characteristics and
differentiation status. We also supplemented chemical in-
duction signals for chondrogenic differentiation to the en-
capsulated mES cells at different time points and evaluated
the outcomes of chondrogenic differentiation via a series of
cartilage-specific markers.
Materials and Methods
Cell culture
mES cells (R1) were kindly provided by Prof. Andras
Nagy (Samuel Lunenfeld Research Institute, Toronto,
Canada),53 and were initially grown on a mitotically inactive
MEF feeder layer at 378C in a 5% CO2 incubator in ES growth
medium, defined as Dulbecco’s modified Eagle’s medium
(DMEM) with high glucose (Gibco, Grand Island,
NY), 0.5mM penicillin and streptomycin (Gibco), 2mM
L-glutamine (Gibco), 1mM nonessential amino acid (Gibco),
1mM sodium pyruvate (Gibco), 20% ES cell-qualified fetal
bovine serum (Gibco), 100mM b-mercaptophenol (Sigma, St.
Louis, MO), and 103 units=mL LIF (Chemicon International,
Temecula, CA). The ES cell growth medium was changed
daily. Cells at subconfluence were detached by 0.05% tryp-
sin=25mmol EDTA (Gibco) for 5min and subcultured on
0.1% gelatin–coated culture plate to maintain a feeder layer–
free culture before microencapsulation for at most three
passages.
Microencapsulation of mES cells
mES cells were microencapsulated as previously de-
scribed.51 In brief, rat tail type I collagen (Becton Dickenson
Biosciences, Bedford, MA) was neutralized by 0.1N NaOH
and diluted into final concentrations of 0.5 and 2.0mg=mL.
ES cells were suspended in neutralized collagen solution to
make up cell–matrix mixtures with a final cell density of
1105 cells=mL (250 cells=2.5 mL droplet). Liquid droplets
were dispensed onto a nonadhesive surface in a 90-mm-
diameter Petri dish (Sterilin, London, United Kingdom) cov-
ered with UV-irradiated parafilm and incubated at 378C
with 5% CO2 for 45min to induce reconstitution of collagen
fiber meshwork as previously described.25 Gelated mES cell–
collagen microspheres were gently flushed with ES growth
medium from the parafilm into the Petri dish and maintained
free-floating in suspensions for various periods of time as
specified subsequently.
Characterization of the mES cell–encapsulated
collagen microspheres
The temporal morphological change of the mES cell–
encapsulated collagen microspheres was recorded under a
phase contrast microscope up to 14 days. The diameters of
both the microspheres and the ES cell aggregates within the
microspheres were measured using an eye-piece micrometer.
Approximately 10–15% of the microsphere populations
(80=dish) were randomly selected and measured. Moreover,
the temporal change of the diameter of 10 randomly selected
microspheres per group per time point was also measured
during chondrogenic differentiation.
Cell viability and growth kinetics
On days 3, 7, 10, and 14 postencapsulation, mES cell–
encapsulated collagen microspheres were incubated with
2 mM calcein AM and 4mM ethidium homodimer-1 in LIVE=
DEAD Viability=Cytotoxicity kit (Molecular Probes, Eugene,
OR) for 1 h for simultaneous staining of live and dead cells.
Stained microspheres were fixed in 4% paraformaldehyde
(PFA) for 1 h and examined using a UV-inverted microscope
(Leica DM IRB, Wetzlar, Germany) for fluorescent images.
The microspheres were examined using a laser-scanning
confocal microscope (Bio-Rad; Radiance 2100, Hercules,
CA). In a separate experiment, 100 microspheres per 90-
mm-diameter Petri dish in duplicates were cultured for 3,
7, 10, and 14 days. Microspheres were digested enzymati-
cally by collagenase from Clostridium histolyticum (Sigma) at
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100 units=mL for 45–60min. mES cell aggregates were re-
leased from the collagen microspheres and then treated with
0.05% trypsin=25mmol EDTA (Gibco) to give a single-cell
suspension, which was rinsed with medium before trypan
blue staining for cell count and viability.
Immunofluorescent staining of markers
for undifferentiated mES cells
Single-mES suspensions were retrieved from collagen mi-
crospheres at different time points postencapsulation and
plated on 0.1% gelatin–coated coverslip overnight. The live
mES cells were stained by calcein AM for 1 h at 378C and then
fixed in 4% PFA at room temperature for 20min. The fixed
mES cells were washed for three times in PBS before immu-
nofluorescent staining. In brief, mES cells were incubatedwith
primary antibodies against undifferentiated ES cell markers,
including Oct3=4 (rat monoclonal, 10mg=mL; R&D Systems,
Minneapolis, MN), SSEA-1 (mouse monoclonal, 1mg=mL;
R&D Systems), and Nanog (rabbit polyclonal, 0.5mg=mL;
Abcam, Cambridge, United Kingdom) in PBS supplemented
with 2% bovine serum albumin (BSA) overnight at 48C. After
thorough rinsing, cells were incubated with secondary anti-
bodies, goat anti-rat IgG, goat anti-mouse IgM, and goat anti-
rabbit conjugated with Alexa 546 (1:500 in PBS; Molecular
Probes), for primary antibodies against Oct3=4, SSEA-1, and
Nanog, respectively, for 1 h at room temperature. ThemES cells
were then rinsed thoroughly andmounted on glass slides with
fluorescent mounting medium (DakoCytomation, Glostrup,
Denmark). mES cells at different time points postencapsulation
were imaged under a UV-inverted microscope (Leica DM IRB;
excitation at 546). Five views were captured, and about 400–
1000 cells were counted in each slide. The live cells were in
green, while the undifferentiated mES cells were in red.
Flow cytometry analysis for platelet derived growth
factor receptor alpha (PDGFRa)-positive MPCs
mES cells encapsulated in 0.5 and 2.0mg=mL collagen
microspheres were cultured for 3, 7, 10, and 14 days in ES cell
growth medium with LIF. Single-mES cell suspensions were
retrieved from collagen microspheres after collagenase di-
gestion followed by trypsin treatment and cell strainer filter-
ing (70mm nylon mesh; BD Falcon, Franklin Lake, NJ) for cell
counting. About 1106 cells were resuspended in 100mL PBS.
NIH=3T3 fibroblasts were used as positive controls as they are
known to express PDGFRa (ATCC, Manassas, VA). Cells
were incubated at room temperature for an hour to allow the
recovery of cell surface protein expression after trypsiniza-
tion. Cells were blocked by 2% BSA in PBS for 30min before
direct staining of antibodies. To each sample, 20mL of
PDGFRa PE-conjugated IgG antibody (Santa Cruz Bio-
technology, CA) was added. Isotype controls (normal rabbit
PE-conjugated IgG antibody [Santa Cruz Biotechnology])
were performed at each time point. After staining at 48C for
30min, 1000 mL PBS was added to each tube to wash off the
excess antibodies. After centrifugation at 2000 rpm for 5min,
the supernatant was removed, and the cell pellets were fixed
by 1% PFA for 20min before resuspending in 300 mL PBS at a
cell density not less than 4105 cells=mL for FACS analysis.
FACSAria Flow Cytometer (BD Biosciences, Bedford, MA)
was used for the analysis.
Induction of chondrogenic differentiation
mES cell–encapsulated collagen microspheres were ex-
posed to chondrogenic differentiation induction signal by
cultivating in a chondrogenic differentiation medium, that is,
DMEM high glucose (Gibco) supplemented with 10 ng=mL
recombinant human transforming growth factor beta 3
(Peprotech, Rocky Hill, NJ), 100 nM dexamethasone (Sigma),
6mg=mL insulin (Merck, Darmstadt, Germany), 100mM 2-
phospho-L-ascorbate (Fluka, St. Louis, MO), 1mM sodium
pyruvate (Gibco), 6mg=mL transferrin (Sigma), 0.35mM L-
prolin (Merck), and 1.25mg=mL BSA (Sigma). The micro-
spheres were cultured in ES cell growth medium for 3, 7, 10,
and 14 days before induction of chondrogenic differentiation
for 21 days.
Histology, histochemistry, and immunohistochemistry
of mES cell–encapsulated microspheres
Both undifferentiated and differentiated mES cell–collagen
microspheres were fixed in 4% PFA at room temperature for
1 h and transferred to a series of ethanol with an increasing
concentration for dehydration before processing for paraffin
sections of 4 mm thickness. Routine hematoxylin and eosin
(Sigma) staining was conducted to reveal the cell morphology
in the microspheres. To evaluate the presence of glycosami-
noglycans (GAGs), sections were stained using 1% Alcian
blue 8 GX (Sigma) in 3% acetic acid (pH 2.5) for 30min and
counterstained by nuclear fast red. To evaluate the presence of
cartilage-specific extracellular matrix type II collagen, a pri-
mary antibody (Rabbit polyclonal, 1.25 mg=mL; Chemicon)
was used. To evaluate the presence of cellular marker of
chondrogenic lineages, Sox-9, a primary antibody (Rabbit
polyclonal, 2mg=mL; Santa Cruz Biotechnology), was used.
Anti-rabbit secondary antibody was used in immunohisto-
chemistry, followed by ABC staining, diaminobenzidine la-
beling, and counterstaining using hematoxylin.
Quantitative analysis for GAGs
1,9-Dimethylmethylene blue (DMMB) assay was used to
determine the GAG content in mES cell–encapsulated mi-
crospheres.54,55 Microspheres in triplicates were digested by
300mg=mL papain (100mL) in 50mM phosphate buffer (pH
6.5) containing 5mMcysteine and 5mMEDTA at 608C for 16–
18 h. The sample solutionsweremixedwith DMMB reagent at
a volume ratio of 1:10 for 30min. The mixtures were then
centrifuged, and the supernatant was discarded. Finally,
GAG precipitates were dissolved in 0.2mL dissociation so-
lution and added to a 96-well plate for absorbance reading at
656 nm using a microplate reader (Safire2 ; Tecan Ma¨nne-
dorf, Switzerland). GAG concentration was calculated by
calibrating against a standard curve of shark chondroitin-6-
sulfate (Sigma) normalized to the DNA content using a fluo-
rometric assay with Hoechst 33258.56 The DNA content was
determined against a standard curve of calf thymus DNA
(Sigma). Both the standard curves of GAG and the DNAwere
constructed using duplicates.
Statistical analysis
Data are presented as means with standard deviations or
95% confidence intervals. The normality assumption was ver-
ified before conducting parametric tests. Two-way ANOVA
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FIG. 1. Morphological and microstructural characterization of mouse embryonic stem (mES) cell–encapsulated collagen
microspheres. Upper panel: phase contrast images of mES cell–collagen microspheres with 0.5mg=mL collagen (A–E) and
2.0mg=mL collagen (F–J) in 3D culture on day 0 (A, F), day 3 (B, G), day 7 (C, H), day 10 (D, I), and day 14 (E, J)
(magnification, 4). Middle panel: (left) change of the mES cell-aggregate size (diameter) within 0.5 and 2.0mg=mL collagen
microspheres after postencapsulated for 3, 7, 10, and 14 days (K). Data are presented as mean standard deviation for n¼ 4.
(Right) H&E staining in cross-sectional views of ES cell aggregates in microspheres with 0.5mg=mL collagen (L–N) and
2.0mg=mL collagen (O–Q) on day 7 (L, O), day 10 (M, P), and day 14 (N, Q) (magnification, 20). Scale bars: 50 mm. Lower
panel: scanning electron microscopic image of mES cell aggregates in collagen microspheres (R) and meshwork of randomly
distributed collagen nanofibers (S). Color images available online at www.liebertonline.com=ten.
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with appropriate post hoc tests was used to compare the
differences in cell number, cell viability, aggregate size, and
expressions of markers for undifferentiated mES cells, and
the extent of contraction upon differentiation. SPSS 16.0 was
used to execute the analyses, and the significance level was
set at 0.05.
Results
Morphological and microstructural characterization
of ES cell–encapsulated collagen microspheres
Upon encapsulation, mES cells were randomly distributed
in the transparent collagen microspheres and proliferated to
form tiny aggregates within the collagen microspheres in the
following 2 days (Fig. 1). The aggregate size increased over
time (Fig. 1A–J). Two-way ANOVA with Dunnett T3 post hoc
test showed that there was a significant difference in aggre-
gate size in all groups ( p< 0.001) (Fig. 1K), where the differ-
ence was due to both the culture period ( p< 0.001) and the
concentration of collagen ( p< 0.05). Significant differences
were found in all groups ( p< 0.05) except the pair between
days 7 and 10 ( p¼ 0.522). Figure 1L–Q shows the H&E
staining of mES cell aggregates in collagen microspheres over
time. On day 3, the aggregates were too small for paraffin
sectioning and were not available for staining. On days 7 and
10, homogenous populations of mES cells were found evenly
distributed throughout the cell aggregates (Fig. 1L, M, O, P).
On day 14, some aggregates fused together to give larger
aggregates (Fig. 1N, Q), which were still largely homogenous
(Fig. 1N), andmore cells had been found inmicrospheres with
0.5mg=mL collagen. Microstructural analysis of the ES cell–
collagen microspheres showed that mES cell aggregates were
FIG. 2. Viability and growth kinetics of mES cells in collagen microspheres. Upper panel: LIVE=DEAD staining of mES cells
in 0.5mg=mL (A–D) and 2.0mg=mL collagen (E–H) on day 3 (A, E), day 7 (B, F), day 10 (C, G), and day 14 (D, H)
(magnification, 5). Scale bars: 200 mm. Green (calcein AM), live cells; red (ethidium homodimer-1), dead cells. Lower panel:
Viability (I) and growth kinetics (J) of mES cells under different culture conditions, including traditional 2D culture in 0.1%
gelatin-coated plate, and 3D culture in microspheres with 0.5mg=mL and 2.0mg=mL collagen microspheres. Data are
presented as means standard deviations for n¼ 4. Color images available online at www.liebertonline.com=ten.
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embedded in a meshwork of randomly distributed collagen
nanofibers (Fig. 1R, S).
Viability and growth kinetics of mES cells
in collagen microspheres
Figure 2A–H shows the simultaneous staining of live and
dead cells of mES cells in collagen microspheres. Almost all
cells were alive in the first 7 days of 3D culture, while some
dead cells were observed since day 10. Quantitative analysis
showed that cell viability was close to 100% in the first week
and slightly reduced in later time points particularly in mi-
crospheres with a higher (2.0mg=mL) collagen concentration
(Fig. 2I). Two-way ANOVA with Dunnett T3 post hoc test
showed that there was a significant difference in viability in
all groups ( p< 0.001), and the difference was due to the time
factor ( p< 0.001), not the culture condition ( p¼ 0.601). Via-
bility on day 14was significantly different from that on days 2
and 4 ( p< 0.05) but not on other time points ( p> 0.05). The
growth curves of mES cells in traditional gelatin-coated cul-
ture plate, and in 3D collagen microspheres with 0.5 and
2.0mg=mL collagen are shown in Figure 2J. mES cells in col-
lagen microspheres proliferated at a much slower rate than
those in a traditional gelatin-coated culture dish with a longer
lag phase and a later log phase. Nevertheless, cell numbers of
collagen microspheres reached the same level as that of the
gelatin-coated culture dish at later time points on days 10 and
14. Two-way ANOVA with Dunnett T3 post hoc test showed
that there was a significant difference between the early (days
2 and 4) and the later time points (days 7, 10, and 14)
( p< 0.05), where the difference was due to both the culture
condition and the time factor ( p< 0.05).
Undifferentiated status of live mES cells
in collagen microspheres
Colocalization of live cells in green and markers for un-
differentiated mES cells in red, namely, Oct3=4, SSEA-1, or
Nanog, was demonstrated (Fig. 3). The upper panel of Figure
3 shows the representative superimposed images of the im-
munofluorescent staining against Oct3=4 at different time
points and with different collagen concentrations (A–H),
while images for SSEA-1 and nanog are shown in the middle
and the lower panels of Figure 3, respectively. Quantita-
tive analysis of the percentage of cells with double-positive
immunofluorescent staining (orange) out of total live cell
populations showed the gradual decreasing trend in the
proportion of undifferentiated mES cells over time (upper,
middle, and lower panels of Fig. 3, picture I). In general, the
proportion of undifferentiated mES cells was greater than
80–90% in the first week in 3D cultures and was decreasing
over time until *70% for Oct3=4 and SSEA-1 and *50%
for Nanog on day 14. mES cells in microspheres with
2.0mg=mL collagen showed a slightly higher percentage in
Oct3=4 than that with 0.5mg=mL collagen at all time points
although this was not the case in other markers. Statistical
analysis on Oct3=4 and SSEA-1 showed that there was a
significant difference between the early (days 3 and 7) and
the later time points (days 10 and 14) ( p< 0.05), where the
difference was due to both the culture period and the con-
centration of collagen ( p< 0.001). Statistical analysis on
Nanog showed that day 14 was significantly different from
days 3, 7, and 10 ( p< 0.05), while day 10 was significantly
different from days 3 and 7 ( p< 0.05). The difference was
due to culture period ( p< 0.001), not the concentration of
collagen ( p¼ 0.435).
Quantitative analysis of proportion of MPCs
in collagen microspheres
Figure 4 shows the percentage of cells expressing
PDGFRa, which is a potential marker for MPCs,21 in collagen
microspheres with different collagen concentrations and at
different time points postencapsulation. The histogram
showed the net percentage of cells expressing PDGFRa after
subtracting the percentage of cells stained by isotype control.
Two-way ANOVA showed that the time factor significantly
affected the percentage of MPCs ( p< 0.05) while the con-
centration factor did not ( p¼ 0.585). Dunnett T3 post hoc test
showed that there was a significant difference between the
early (day 3) and the later time points (days 7, 10, and 14)
( p< 0.05).
Morphological characterization of chondrogenical
differentiated cells in collagen microspheres
H&E staining showed the morphological changes of
cells after induction of chondrogenic differentiation at differ-
ent time points and in microspheres with different colla-
gen concentrations (Fig. 5). mES cells in microspheres with
0.5mg=mL collagen were differentiated into chondrocyte-like
cells, which are round cells with lacunae, when mES cells
were exposed to chondrogenic differentiation signals at later
time points (7, 10, and 14 days postencapsulation) (Fig. 5A–C).
When chondrogenic differentiation was initiated at an early
time point at day 3 postencapsulation, mES cells could not be
differentiated at all and were all dead (data not shown). Upon
differentiation induction at 7 days postencapsulation, the cell
aggregates started to fuse together to form a huge aggregate
and the microsphere encapsulating them contracted. Clusters
of chondrocyte-like cells were identified in the microsphere
(Fig. 5A). As the time to initiate the chondrogenic differenti-
ation postponed to 10 days postencapsulation, more and
larger clusters of chondrocyte-like cells with larger lacunae
structures were identified (Fig. 5B). This phenomenon was
more obvious when differentiation was initiated at a later
time point at 14 days postencapsulation, as characterized by
extensively contracted microspheres, more homogenous
cartilage-like structures with chondrocyte-like cells sitting
around larger lacunae structures throughout the microsphere
(Fig. 5C). However, mES cells in microspheres with 2.0mg=
mL collagen could not be successfully differentiated into
chondrocyte-like cells when they were exposed to chondro-
genic differentiation signals (Fig. 5D–F). Specifically, when
differentiation was initiated at 7 days postencapsulation, mES
cell density was dramatically decreased after 21 days of dif-
ferentiation (Fig. 5D). Although the cell densities did not alter
significantly when differentiation was initiated at later time
points at days 10 and 14 postencapsulation, most, if not all,
cells were eosinophilic and no chondrocyte-like cells could be
identified (Fig. 5E, F). Quantitative analysis on the diameter of
collagen microspheres before and after chondrogenic differ-
entiation is shown in Figure 5G–J. Two-way ANOVA with
Dunnett T3 post hoc test showed that there was no significant
temporal change in diameter of microsphere before chon-
drogenic differentiation is initiated ( p> 0.05) (Fig. 5G).
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FIG. 3. Expression of markers for live and undifferentiated mES cells in collagen microspheres. Upper panel: double
immunofluorescent staining of Oct3=4 and calcein AM on mES cells from microspheres with 0.5mg=mL collagen (A–D) and
2.0mg=mL collagen (E–H) on day 3 (A, E), day 7 (B, F), day 10 (C, G), and day 14 (D, H), and histogram on the percentage of
live mES cells expressing Oct3=4 (I). Middle panel: double immunofluorescent staining of SSEA-1 and calcein AM on mES
cells from microspheres with 0.5mg=mL collagen (A–D) and 2.0mg=mL collagen (E–H) on day 3 (A, E), day 7 (B, F), day 10
(C, G), and day 14 (D, H), and histogram on the percentage of live mES cells expressing SSEA-1 (I). Lower panel: double
immunofluorescent staining of Nanog and calcein AM on mES cells from microspheres with 0.5mg=mL collagen (A–D) and
2.0mg=mL collagen (E–H) on day 3 (A, E), day 7 (B, F), day 10 (C, G), and day 14 (D, H), and histogram on the percentage of
live mES cells expressing Nanog (I). Data are presented as means standard deviations for n¼ 6 (magnification, 20). Scale
bar: 50mm. Red: Oct3=4, SSEA-1, or Nanog, markers for undifferentiated status of mES cells; green: calcein AM, marker for
live cells released from collagen microspheres. Color images available online at www.liebertonline.com=ten.
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However, there was a significant change after the induction of
chondrogenic differentiation on day 7 (Fig. 5H), day 10 (Fig.
5I), and day 14 (Fig. 5J), and the difference was due to both the
time to induce differentiation and the concentration of colla-
gen ( p< 0.001).
Histochemical and biochemical characterization
of differentiated cells in collagen microspheres
Alcian blue staining showed GAG-rich regions in the mES
cell–encapsulated microspheres after 21 days of chondro-
genic induction at 7, 10, and 14 days postencapsulation
(Fig. 6A–F). In microspheres with 0.5mg=mL collagen, a
number of GAG-rich regions could be identified in the mi-
crospheres after chondrogenic differentiation when induced
at day 7 postencapsulation (Fig. 6A), and the location of
these regions matched well with clusters of chondrocyte-like
cells in H&E staining (Fig. 6A). When chondrogenic differ-
entiation was induced at day 10 postencapsulation, Alcian
blue staining was more homogenous throughout the micro-
sphere, and there were more GAG-rich regions with more
intense staining (Fig. 6B), matching with the presence of
chondrocyte-like cell clusters (Fig. 6B). In microspheres dif-
ferentiated at a later time point on day 14 postencapsulation,
extensive staining of GAGs associated with homogenous
cartilage-like structures, which were characterized by large
chondrocytes in lacunae throughout the microsphere (Fig.
6C). This also matched well with the cartilage-like structures
in H&E staining (Fig. 5C). On the other hand, microspheres
with 2.0mg=mL collagen showed negative Alcian blue
staining in all conditions (Fig. 6D–F). Figure 6G shows the
normalized GAG content of the microspheres with and
without chondrogenic differentiation medium supplemented
at different time points postencapsulation. Induction of dif-
ferentiation at a later time point did not significantly af-
fect the GAG content, while when the differentiation started
at later time points (10 and 14 days postencapsulation), the
GAG content significantly increased compared with the
control group. Statistically, two-way ANOVA with T3 post
hoc test showed that there was a significant difference
in GAG=DNA ratio among different groups ( p< 0.05), and
the difference was due to both the time factor and the dif-
FIG. 4. Flow cytometry analysis of markers for mesenchymal progenitor cells. (A) Profile of cells labeled with anti-PDGFRa
antibody conjugated with PE fluorescent signal (orange) in mES cells cultured in monolayers and in microspheres with 0.5 and
2.0mg=mL initial collagen concentration on days 3, 7, 10, and 14. (B) Histogram showing the proportion of cells expressing
platelet derived growth factor receptor a (PDGFRa) under different 3D culture conditions after subtracting the isotype control.
Data are presented as mean standard deviation for n¼ 2. Color images available online at www.liebertonline.com=ten.
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ferentiation group factor ( p< 0.05). In particular, the GAG=
DNA ratio was significantly increased when the differentia-
tion was initiated at a later time point on day 14 post-
encapsulation ( p< 0.05) but not on other time points
( p> 0.05).
Immunohistochemical characterization
of differentiated cells in collagen microspheres
Positive immunoreactivity against another cartilage-
specific extracellular matrix marker type II collagen was
FIG. 5. Morphological characterization of differentiated cells in collagenmicrospheres.Upper panel:H&E staining of differentiated
cells in collagenmicrospheres. Cross-sectional views of 0.5mg=mL (A–C) and 2.0mg=mL collagenmicrospheres (D–F) after 21 days
of chondrogenic differentiation. Chondrogenic differentiation induction starts on day 7 (A, D), day 10 (B, E), and day 14 (C, F) after
encapsulation (magnification, 20). Scale bars: 50mm.Lower panel: diameters of 0.5 and 2.0mg=mLcollagenmicrospheres (G) before
and (H–J) during chondrogenic differentiation. The induction of chondrogenic differentiation were on day 7 (H), day 10 (I), and day
14 (J). Data are presented as mean standard deviation for n¼ 4. Color images available online at www.liebertonline.com=ten.
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found in both the chondrocyte-like cells and the extracellular
matrix in microspheres with 0.5mg=mL collagen (Fig. 7A–C).
Staining was more homogenous and intense when chondro-
genic differentiation was initiated on day 10 postencapsula-
tion (Fig. 7B), and more intensive staining was found when
differentiation started on day 14 (Fig. 7C). In microspheres
with 2.0mg=mL collagen, type II collagen was stained posi-
tively only in some cells when differentiationwas induced at 7
days postencapsulation (Fig. 7D) but negatively in all other
conditions (Fig. 7E, F). Immunolocalization of the nuclear
FIG. 6. Histochemical and biochemical characterization of differentiated cells in collagen microspheres. Upper panel: Alcian
blue staining of differentiated cells in collagen microspheres. Cross-sectional views of 0.5mg=mL (A–C) and 2.0mg=mL
collagen microspheres (D–F) after 21 days of chondrogenic differentiation. Chondrogenic differentiation induction starts
on day 7 (A, D), day 10 (B, E), and day 14 (C, F) after encapsulation. Blue: Alcian blue staining for proteoglycan
(PG)=glycosaminoglycan (GAG)–rich matrix; red: nuclear fast red counterstain (magnification, 20). Scale bars: 50mm. Lower
panel: GAG=DNA content in 0.5mg=mL collagen microspheres was quantified by 1,9-dimethylmethylene blue assay and
expressed as GAG=DNA (G). GAG=DNA of microspheres chondrogenically differentiated from day 7 was no significant
different before and after 21 days differentiation but increased from days 10 and 14 after 21 days differentiation. Data are
presented as mean standard deviation for n¼ 2. Color images available online at www.liebertonline.com=ten.
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FIG. 7. Immunohistochemical characterization of type II collagen and Sox-9 staining of differentiated cells in collagen micro-
spheres. Upper panel: cross-sectional views of 0.5mg=mL (type II collagen, A–C; Sox-9, G–L) and 2.0mg=mL collagen micro-
spheres (type II collagen,D–F; Sox-9,M–O) after 21 days of differentiation. Lower panel: cross-sectional views ofmicrospheres on
Sox-9 of 0.5mg=mL collagen microspheres with a higher magnification (J–L) after 21 days of chondrogenic differentiation. The
positive staining was indicated by diaminobenzidine on matrix with counterstain (magnification, 20). Scale bars: 50mm. Color
images available online at www.liebertonline.com=ten.
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staining for Sox-9 showed that mES cells were successfully
differentiated toward the chondrogenic lineage (Fig. 7G–L).
Positive staining was found in chondrocyte-like cells in re-
gions closely associated with the GAG-rich area (Fig. 6A–C)
and the type II collagen immunopositive region (Fig. 7A–C) in
the extracellular matrix of microspheres with 0.5mg=mL col-
lagen. No positive staining for Sox-9 was detected in micro-
spheres with 2.0mg=mL (Fig. 7M–O).
Discussion
An efficient 3D culture system for mES cell
This study has reported a new approach to culture mES
cells in 3D configuration using collagen microencapsulation.
In this system, mES cells proliferate inside the collagen mi-
crospheres to form cell aggregates. These cell aggregates differ
fromEBs in both themethod of formation and their structures.
Specifically, EBs are generated by forced aggregation using
hanging drops or centrifugal force in the absence of LIF, while
the cell aggregates in the current study are formed by prolif-
eration of single-mES cells encapsulated in the collagenmicro-
spheres and are therefore similar to those single-cell-derived
colonies. Second, cells in EBs spontaneously differentiate to
form multiple tissue-like structures and cavities,11,12,57 while
cell aggregates in the current 3D culture system are composed
of homogenous cell populations without tissue-like structures
and cavities. Although the proliferation rate of mES cells in
the 3D culture system is initially slower than the traditional
2D cultures (84-fold versus 275-fold of expansion on day 7),
the total number of mES cells expanded reached the same
level at later time points (230-fold of expansion at 10 days).
This indicates that this 3D culture system is at least as efficient
as the traditional 2D system in terms of the magnitude of
cell expansion. Moreover, this 3D culture system is able to
maintain the undifferentiated status of more than 80% of mES
cells for at least 1 week. Nevertheless, the percentage of un-
differentiated mES cells gradually decreased at later time
points, accompanied by an increasing proportion of MPCs,
even though LIF was supplemented. This indicates that col-
lagen matrix may play an inductive role in differentiating
mES cells toward mesenchymal lineages.
Matrix microenvironment affects the mES cell fate
mES cells were able to differentiate toward a chondrogenic
lineage upon supplementation of induction signals to mi-
crospheres with a lower initial collagen concentration
(0.5mg=mL), as suggested by both cellular and extracellular
markers of cartilage formation, including the chondrocyte-
like morphology, positive immunolocalization of Sox-9 in the
nuclei, extensively stained GAG-rich areas and significantly
increased GAG content, and high immunoreactivity against
type II collagen in the extracellular matrix. On the other
hand, mES cells cultured in microspheres with a higher
collagen concentration (2.0mg=mL) failed to differentiate
toward the chondrogenic lineage, as suggested by the ab-
sence of chondrocyte-like morphology and Sox-9 expression
in all cells and the negative staining for GAG and type II
collagen extracellular matrix. The physical information such
as the stiffness or the mechanical compliance of the collagen
matrix with different concentrations sensed by the encapsu-
lated mES cells may be different. Microspheres with ini-
tial collagen concentration of 0.5mg=mL are less stiff than
that of 2.0mg=mL, and therefore provide less mechanical
constrains to the encapsulated cells. Upon differentiation of
mES cells, a lower collagen concentration allows greater ex-
tent of cell-induced contraction of the collagen fiber mesh-
work. This results in higher local cell density and hence
greater cell–cell interaction, analogous to what occurs during
cellular condensation process preceding chondrogenic dif-
ferentiation in embryonic skeletal development.58,59 The
transient N-cadherin signaling, which is exerted by cell–cell
contact, has been demonstrated to be highly essential for
chondrogenic differentiation of progenitor cells.59 On the
other hand, collagen at 2.0mg=mL provides greater me-
chanical constrain to the encapsulated cells and reduces the
extent of cell-induced contraction of the collagen fiber
meshwork upon differentiation. As a result, reduced cell–cell
interaction and absence of cellular condensation may lead to
the inhibition of chondrogenic differentiation in micro-
spheres with 2mg=mL of the initial collagen concentration.
Effects of collagen concentration and local cell density on the
outcomes of chondrogenic differentiation have also been
reported in our previous study using bone marrow MSCs.52
Recently, stem cells have been shown to respond to their
physical microenvironment,60 including matrix elasticity,61,62
matrix mechanical compliance,63 and mechanical loading
signals such as cyclic strain.64 A recent report investigates the
effects of collagen concentration on EB formation and dem-
onstrated that a higher collagen concentration at 2.4mg=mL
inhibited cell apoptosis, which is necessary for differentiation
and normal cavitation in EBs, and thus the subsequent dif-
ferentiation toward fibrocartilage.11
Time to induce differentiation affects the mES cell fate
Collagen concentration is a dominating factor, but the
time to supplement the induction signals of chondrogenic
differentiation to the mES cell–encapsulated microspheres
also matters. Early exposure of mES cell aggregates at 3 days
postencapsulation did not result in successful chondrogenic
differentiation and all cells are dead after 21 days of differ-
entiation (data not shown). This may be due to the lack of
cell–cell contact, which is essential for chondrogenic differ-
entiation,59 on day 3 postencapsulation. However, when the
induction signals were applied to the aggregates at later time
points (7 and 14 days postencapsulation), chondrogenic dif-
ferentiation is successful, and cartilage-like structures were
resulted. Moreover, the extent of chondrogenic differentia-
tion seems to positively associate with the timing to induce
differentiation, as revealed qualitatively by the homogeneity
and the relative proportion of cartilage-like tissue in the
microsphere, and quantitatively by the increasing GAG con-
tent. Chondrogenic differentiation of mES cells is a multistep
process. First, mES cells will commit into MPCs, which then
condense into chondroblasts and further differentiate into
chondrocytes.16 Here we demonstrated that the longer the
mES cells are cultured in the collagen microsphere preceding
induction of differentiation, the more the MPCs, which are
able to contract the collagen gel, are formed. The increased
contraction resulted in a higher local cell density and bet-
ter cell–cell interaction and therefore a more homogenous
cartilage-like structure. Cell-induced collagen contraction has
been reported as a functional assay for anchorage-dependent
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cells such as fibroblasts65,66 and myofibroblasts.67 We also
demonstrated that bone marrow MSCs also contract collagen
gel in a cell density–dependent manner.51 It has been sug-
gested that contraction is a result of close interactions between
mesenchymal cells and loose collagen fibrils such as cellular
adhesion plaque formation on the collagen fibrils and cellular
migration through the collagen fibrils.68,69 Nevertheless, no
contraction is resulted in anchorage-independent cells, which
do not closely interacting with collagen, such as mES cells,
neural stem cells, neural crest cells, HEK293 cells, and bone
marrow hematopoietic stem cells (data not shown). This ex-
plains why no contraction is observed before induction for
chondrogenic differentiation, while significant contraction is
noted after the induction for chondrogenic differentiation.
The increasing proportion of MPCs also explains the greater
extent of contraction when chondrogenic differentiation was
induced at later time points. Moreover, the current study
echoes with a recent report, in which the time line to induce
chondrogenic differentiation in EBs has been shown to affect
the outcomes in fibrocartilage development,12 on the signifi-
cance of identifying the appropriate window for differentia-
tion induction in stem cells.
Conclusions
A 3D culture system for mES cells using collagen encap-
sulation has been established in this study. The reconstituted
collagen matrix in the microspheres provides a suitable 3D
microenvironment supporting growth of mES cells and
maintaining their undifferentiated status for a certain period
of time. In this 3D culture system, mES cells can be differen-
tiated directly toward chondrogenic lineages without going
through the EB formation stage. Collagen concentration has
been demonstrated to be the dominating factor in affecting the
outcomes of chondrogenic differentiation as a lower concen-
tration facilitated the chondrogenic differentiation but a
higher concentration failed to do so. This demonstrates the
importance of extracellularmatrixmicroenvironment or niche
in affecting the fate of ES cells. Moreover, a later exposure to
the induction signal associates with an increased proportion
of MPCs and formation of a more homogenous cartilage tis-
sue. This suggests that the timing to induce chondrogenic
differentiation in this 3D culture system is also important in
affecting the outcomes of differentiation and indicates that
collagen matrix may induce the commitment of undifferen-
tiated mES cells to MPCs.
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